Skip to main content

Advertisement

Log in

Regulation of Bone Mineral Density in Morbidly Obese Women: A Cross-sectional Study in Two Cohorts Before and After Bypass Surgery

  • Research Article
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

The mechanisms by which increased body weight influence bone mass density (BMD) are still unknown. The aim of our study was to analyze the relationship between anthropometric and body composition variables, insulin growth factor-I (IGF-I), adiponectin and soluble tumor necrosis factor-α receptors (sTNFR) 1 and 2 with BMD in two cohorts of morbid obese patients, before and after bypass surgery.

Methods

The first cohort included 25 women aged 48 ± 7.6 years studied before bypass surgery. The second included 41 women aged 46 ± 9.2 years, 12 months after surgery. We studied anthropometric variables obtained from whole body DEXA composition analysis. Serum IGF-I, intact serum parathyroid hormone, 25-hydroxivitamin D3, plasma adiponectin concentrations, sTNFR1, sTNFR2 concentrations were measured.

Results

In the first cohort, the BMI was 44.5 ± 3.6 kg/m2, parathyroid hormone, IGF-I, and adiponectin concentrations were lower, and sTNFR1 concentrations were higher than in the second cohort. In the multiple regression analysis, BMD remained significantly associated with body fat percentage (β −0.154, p = 0.01), lean mass (β 0.057, p = 0.016) and phosphate concentration (β 0.225, p = 0.05). In the second cohort, BMI was 31 ± 5.1 kg/m2. In the multiple regression analysis, BMD remained significantly associated with lean mass (β 0.006, p = 0.03).

Conclusion

The inverse correlation found between body fat and BMD in the first cohort indicates morbid obesity increases the risk of osteoporosis and we found a positive correlation with lean and fat mass before bariatric surgery and with lean mass after bypass surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tremollieres FA, Pouilles JM, Ribot C. Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausic women. J Clin Endocrinol Metab. 1993;77:683–6.

    CAS  PubMed  Google Scholar 

  2. Morberg CM, Tetens I, Black E, et al. Leptin and bone mineral density: a cross-sectional study in obese and non obese men. J Clin Endocrinol Metab. 2003;88:5795–800.

    Article  CAS  Google Scholar 

  3. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2001;60:329–39.

    Article  CAS  Google Scholar 

  4. Kleerekoper M, Nelson DA, Peterson EL, et al. Body composition and gonadal steroids in older white and black women. J Clin Endocrinol Metab. 1994;79:775–9.

    CAS  PubMed  Google Scholar 

  5. Reid D, Evans M, Cooper G, et al. Circulating insulin levels are related to bone density in normal postmenopausal women. Am J Physiol. 1993;265:293–7.

    Google Scholar 

  6. Gómez JM. Sex and age differences in serum leptin, insulin-like growth factor-I components and sex-hormone binding globulin in a healthy population. Prot Pept Lett. 2007;14:708–11.

    Article  Google Scholar 

  7. Gómez JM, Maravall FJ, Gómez N, et al. The IGF-I system component concentration that decrease with ageing are lower in obesity in relationship to body mass index and body fat. Growth Horm & IGF Res. 2004;14:91–6.

    Article  Google Scholar 

  8. Vendrell J, Broch M, Vilarrasa N, et al. Resistin, adiponectin, ghrelin, leptin and proinflammatory cytokines: relationships in obesity. Obes Surg. 2004;12:962–71.

    CAS  Google Scholar 

  9. Vilarrasa N, Vendrell J, Maravall J, et al. Distribution and determinants of adiponectin, resistin and ghrelin in randomly selected healthy population. Relationship with IGF-I system. Clin Endocrinol (Oxf). 2005;63:329–35.

    Article  CAS  Google Scholar 

  10. Díez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003;148:293–300.

    Article  Google Scholar 

  11. Hotamisligil GS, Arner P, Caro JF, et al. Increased adipose tissue expression of tumor necrosis alpha in human obesity and insulin resistance. J Clin Invest. 1995;95:2409–15.

    Article  CAS  Google Scholar 

  12. Wood IS, Wang B, Jenkins JR, Trayhurn P. The pro-inflammatory cytokine IL-18 is expressed in human adipose tissue and strongly upregulated by TNF alpha in human adipocytes. Biochem Biophys Res Commun. 2005;337:422–9.

    Article  CAS  Google Scholar 

  13. Hamrick MW, Pennington C, Newton D, et al. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone. 2004;34:376–83.

    Article  CAS  Google Scholar 

  14. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941–6.

    Article  CAS  Google Scholar 

  15. Straczkowski M, Kowalska I, Nikolajuk A, et al. Increased serum interleukin-18 is associated with hypoadiponectinemia in obesity, independently of insulin resistance. Intern J Obes. 2006;31:221–5.

    Article  Google Scholar 

  16. Lenchik L, Register TC, Hsu F-C, et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone. 2003;33:646–51.

    Article  CAS  Google Scholar 

  17. Oh KW, Lee WY, Rhee EJ, et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf). 2005;63:131–8.

    Article  CAS  Google Scholar 

  18. Sambrook P. Tumor necrosis factor blockade and the risk of osteoporosis: back to the future. Arthritis Res Ther. 2007;9:107.

    Article  Google Scholar 

  19. Capella RF, Capella JF. Reducing early technical complications in gastric by-pass surgery. Obes Surg. 1997;7:149–57.

    Article  CAS  Google Scholar 

  20. Molina A, Vendrell J, Gutiérrez C, et al. Insulin resistance, leptin and TNF-α system in obese morbid women after gastric bypass surgery. Obes Surg. 2003;13:615–21.

    Article  Google Scholar 

  21. Gómez JM, Maravall FJ, Gómez N, et al. 25-(OH) D3 regulation in a healthy population randomly selected. Horm Metab Res. 2004;36:48–53.

    Article  Google Scholar 

  22. Gómez JM. The role of insulin-like growth factor I components in the regulation of vitamin D. Curr Pharm Biothec. 2006;7:125–32.

    Article  Google Scholar 

  23. World Health Organization. Obesity: preventing and managing the global epidemic. Report on a WHO consultation on obesity. WHO/NUT/NCD/98.1. Geneva: WHO, 3–5 June, 1997.

  24. El-Kadre LJ, Rocha PR, de Almeida Tinoco AC, et al. Calcium metabolism in pre- and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2005;14:1062–6.

    Article  Google Scholar 

  25. Ybarra J, Sánchez-Hernández I, Gich T, et al. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg. 2005;15:330–5.

    Article  Google Scholar 

  26. Goode LR, Brolin RE, Chowdhury HA, et al. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res. 2004;12:40–7.

    Article  CAS  Google Scholar 

  27. Maeda K, Takahashi M, Funahashi T, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, and adipose-derived protein. Diabetes. 2001;50:2094–9.

    Article  CAS  Google Scholar 

  28. Vilarrasa N, Vendrell J, Sánchez-Santos R, et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumor necrosis factor-α receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol (Oxf). 2007;67:679–86.

    Article  CAS  Google Scholar 

  29. Kontogianni MD, Dafni UG, Routsias JG, et al. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res. 2004;19:546–51.

    Article  CAS  Google Scholar 

  30. Seriolo B, Paolino S, Sulli A, et al. Bone metabolism exchanges during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. Ann N Y Acad Sci. 2006;1069:420–7.

    Article  CAS  Google Scholar 

  31. Santos JL, Lera L, Pérez-Bravo F, et al. Adiposity and bone mineral density of Chilean elderly women in relation to toll-like receptor 4 gene polymorphisms. Ann Hum Biol. 2006;33:585–92.

    Article  CAS  Google Scholar 

  32. Núñez NP, Carpenter CL, Perkins SN, et al. Extreme obesity reduces bone mineral density: complementary evidence from mice and women. Obesity. 2007;15:1980–7.

    Article  Google Scholar 

  33. Edelstein SL, Barrett-Connor E. Relation between body size and bone mineral density in elderly men and women. Am J Epidemiol. 1993;138:160–9.

    Article  CAS  Google Scholar 

  34. Reid I, Plank LD, Evans MC. Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab. 1992;75:779–82.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José Manuel Gómez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gómez, J.M., Vilarrasa, N., Masdevall, C. et al. Regulation of Bone Mineral Density in Morbidly Obese Women: A Cross-sectional Study in Two Cohorts Before and After Bypass Surgery. OBES SURG 19, 345–350 (2009). https://doi.org/10.1007/s11695-008-9529-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-008-9529-4

Keywords

Navigation